Philadelphus tenuifolius
Philadelphus tenuifolius · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Philadelphus tenuifolius is a botanical species currently being investigated for its potential therapeutic properties in modern medicine. Research focuses specifically on the bioactive compounds found within its leaf. Scientists are examining the efficacy of leaf extract as a potential treatment for infectious respiratory diseases. This study is particularly significant due to the rising global threat of tuberculosis and the emergence of drug-resistant tuberculosis. Understanding the medicinal value of this plant could provide new avenues for combating these challenging pathogens.
- Synonyms
- Philadelphus Coronarius Var. Tenuifolius · Philadelphus Lasiogynus · 10 more
- Common names
- Not available
- Family
- Hydrangeaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Leaf
Classification
Common Names
Philadelphus tenuifolius is a versatile flowering shrub known by several distinct names across different languages and regions. In English-speaking areas, it is most frequently referred to as the slender-leaf mock orange or the amur jasmine. Its diverse identity extends into German-speaking regions, where it is commonly called the Mandschurischer Pfeifenstrauch. This botanical variety also holds specific regional names in Czech, such as pajazmín tenkolistý and pustoryl tenkolistý. Understanding these various common names helps gardeners and botanists alike identify this specific species regardless of their linguistic background.
Sources: Catalogue of Life (COL)
Synonyms
Philadelphus tenuifolius is a complex species that has been identified through various botanical classifications over time. It is frequently recognized by its synonym Philadelphus coronarius var. tenuifolius in certain taxonomic circles. The plant is also closely associated with the name Philadelphus koreanus, which highlights its regional botanical connections. Furthermore, it shares nomenclatural ties with Philadelphus koreanus var. robustus and the distinct Philadelphus lasiogynus. Ultimately, these various designations, including Philadelphus robustus, reflect the intricate and evolving history of its scientific identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Philadelphus tenuifolius belongs to the vast kingdom Plantae, representing a diverse branch of the natural world. Within this biological hierarchy, the species is classified under the class Equisetopsida. It further resides in the order Cornales, which helps scientists understand its evolutionary lineage. As a member of the family Hydrangeaceae, it shares botanical characteristics with many well-known flowering shrubs. Ultimately, this plant is defined by its placement within the specific genus Philadelphus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Cornales |
| Family | Hydrangeaceae |
| Genus | Philadelphus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Philadelphus tenuifolius is a resilient species primarily distributed throughout the Asia-Temperate regions. Its natural range extends across Central Asia, specifically within the borders of Uzbekistan. In East Asia, the plant is widely established throughout China, including the provinces of Inner Mongolia and Manchuria. It can also be found thriving in the eastern reaches of Korea. Furthermore, its habitat includes the Amur region of the Russian Far East, showcasing its broad geographic footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Philadelphus tenuifolius is a graceful shrub characterized by its distinct growth habit. This species typically reaches a maximum height of 2.3 meters, making it a versatile addition to any landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Philadelphus tenuifolius leaf extract demonstrates significant anti-tuberculosis activity by effectively treating tuberculosis in various forms. The extract has been shown to treat intracellular Mycobacterium tuberculosis by reducing the bacterial load within macrophages. Furthermore, its therapeutic potential extends to treating both drug-sensitive and drug-resistant tuberculosis. By addressing these different strains, the plant serves as a promising candidate for treating drug-resistant Mycobacterium tuberculosis. These combined capabilities highlight the plant's efficacy as a versatile host-directed therapeutic agent.
Preparations
Philadelphus tenuifolius is prepared as a leaf extract through a process of 50% ethanolic extraction. This specific PT-LE extract is being investigated for its significant anti-tuberculosis potential against Mycobacterium tuberculosis. By utilizing this leaf extract, researchers found that the MAPK signaling pathway is activated to enhance host autophagy flux. The extract also demonstrates the ability to work synergistically with conventional anti-tuberculosis drugs to reduce bacterial loads. Ultimately, the leaf extract of Philadelphus tenuifolius serves as a promising host-directed therapeutic candidate for treating tuberculosis.
Parts used
Philadelphus tenuifolius is a Korean aromatic herb that holds significant potential for modern medicinal applications. Recent scientific investigations have focused specifically on the therapeutic properties found within the plant's leaf. By utilizing a 50% ethanolic extraction of the leaf, researchers developed a concentrated extract known as PT-LE. This extract has demonstrated a remarkable ability to reduce the bacterial load of intracellular Mycobacterium tuberculosis within macrophages. Ultimately, the leaf serves as a promising host-directed therapeutic candidate by enhancing autophagy and strengthening the immune response.